Search results
Results From The WOW.Com Content Network
Mallinckrodt acquired this product via its acquisition of Questcor Pharmaceuticals in 2014. [81] When Questcor acquired the drug in 2001 it sold for $40 a vial; within a year of the acquisition Questcor raised the price of the drug to $1,500 per vial and to $28,000 by 2013. [82]
What: Shares of Questcor Pharmaceuticals , a. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ways to reach us. Mail. Sign in ...
Congratulations! Maybe. If you owned shares in Questcor Pharmaceuticals (NAS: QCOR) before Oct. 29, you have good news. You will be the recipient of the biotech's first-ever dividend payment.
So what: The stock has been pressured in recent months on concerns that reimbursement issues would hurt sales of its H.P. Acthar gel, but today's blowout second quarter -- profit jumped 67% on a ...
After a massive sell-off in shares this fall, a lot of questions have arisen around the ultimate opportunity that Questcor Pharmaceuticals (NAS: QCOR) shares present to investors. Is this one ...
Questcor (Nasdaq: QCOR ) is a smaller player in the biotech space that has garnered a lot of attention on Fool.com. In this video, Motley Fool health-care bureau chief Brenton Flynn talks about ...
Questcor is one of the most shorted health-care stocks on the market. Despite the company's profitability and strong cash flow, shares have taken a big hit as concerns arose regarding its top ...
It has been approximately a year since the Citron Research report about Questcor Pharmaceuticals came out, which caused the stock to lose more than half of its value. At the time, most of the ...